Platelet-activating factor induces up-regulation of antiapoptotic factors in a melanoma cell line through nuclear

Kook Heon Seo1, Hyun-Mi Ko, Han-A Kim

  • 1Department of Biological Sciences, The Institute of Basic Sciences, Chonnam National University, Kwangju, Republic of Korea.

Cancer Research
|May 3, 2006
PubMed

Insights

Platelet-activating factor (PAF) promotes melanoma cell survival by increasing antiapoptotic factors via nuclear factor-kappaB (NF-kappaB). This suggests PAF may reduce chemotherapy effectiveness in B16F10 melanoma.

Area of Science:

  • Oncology
  • Cell Biology
  • Immunology

Background:

  • Melanoma cell proliferation and apoptosis are critical factors in cancer progression.
  • Platelet-activating factor (PAF) is implicated in various cellular processes, including inflammation and cell survival.
  • Understanding molecular mechanisms regulating melanoma cell fate is crucial for developing effective cancer therapies.

Purpose of the Study:

  • To investigate the role of platelet-activating factor (PAF) in modulating apoptosis-regulating factors in B16F10 melanoma cells.
  • To elucidate the involvement of nuclear factor-kappaB (NF-kappaB) signaling in PAF-mediated effects on melanoma cells.
  • To assess the impact of PAF on the efficacy of chemotherapeutic agents in melanoma models.

Main Methods:

  • Quantitative real-time PCR to measure mRNA expression of apoptosis-regulating factors.
  • Western blotting to assess protein synthesis of antiapoptotic and proapoptotic factors.
  • Inhibition studies using a selective nuclear factor-kappaB (NF-kappaB) inhibitor, parthenolide.
  • Enzyme activity assays for caspases (caspase-3, -8, -9).
  • In vivo studies using a Matrigel-based subcutaneous model with B16F10 melanoma cells.

Main Results:

  • PAF significantly increased mRNA and protein expression of antiapoptotic factors Bcl-2 and Bcl-xL in B16F10 cells.
  • PAF did not increase the expression of the proapoptotic factor Bax.
  • Inhibition of NF-kappaB by parthenolide blocked PAF-induced changes in antiapoptotic factors.
  • PAF attenuated etoposide-induced increases in caspase activities and melanoma cell death.
  • PAF promoted B16F10 cell growth in vivo and reduced the inhibitory effect of etoposide.

Conclusions:

  • Platelet-activating factor (PAF) induces the up-regulation of antiapoptotic factors, specifically Bcl-2 and Bcl-xL, in a melanoma cell line.
  • This effect is dependent on nuclear factor-kappaB (NF-kappaB) signaling.
  • PAF may reduce the cytotoxic efficacy of chemotherapeutic agents like etoposide by promoting melanoma cell survival.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...